950 related articles for article (PubMed ID: 33144266)
21. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
22. [Follow-up of patients treated for an epithelial ovarian cancer, place of hormone replacement therapy and of contraception: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
Sénéchal C; Akladios C; Bendifallah S; Ouldamer L; Lecuru F; Rousset-Jablonski C
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):250-262. PubMed ID: 30685388
[TBL] [Abstract][Full Text] [Related]
23. Controversies in borderline ovarian tumors.
Seong SJ; Kim DH; Kim MK; Song T
J Gynecol Oncol; 2015 Oct; 26(4):343-9. PubMed ID: 26404125
[TBL] [Abstract][Full Text] [Related]
24. Conservative management of epithelial ovarian cancer.
Dexeus S; Labastida R; Dexeus D
Eur J Gynaecol Oncol; 2005; 26(5):473-8. PubMed ID: 16285560
[TBL] [Abstract][Full Text] [Related]
25. Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis.
Li N; Ming X; Li Z
Arch Gynecol Obstet; 2020 Nov; 302(5):1063-1074. PubMed ID: 32748055
[TBL] [Abstract][Full Text] [Related]
26. Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors.
Plett H; Harter P; Ataseven B; Heitz F; Prader S; Schneider S; Heikaus S; Fisseler-Eckhoff A; Kommoss F; Lax SF; Staebler A; Traut A; du Bois A
Gynecol Oncol; 2020 May; 157(2):411-417. PubMed ID: 32115229
[TBL] [Abstract][Full Text] [Related]
27. Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility.
Wang P; Fang L
World J Surg Oncol; 2021 Apr; 19(1):132. PubMed ID: 33882931
[TBL] [Abstract][Full Text] [Related]
28. Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology.
Lavoue V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lecuru F; Lefrere-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Senechal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
J Gynecol Obstet Hum Reprod; 2019 Jun; 48(6):369-378. PubMed ID: 30936027
[TBL] [Abstract][Full Text] [Related]
29. The value of random biopsies, omentectomy, and hysterectomy in operations for borderline ovarian tumors.
Kristensen GS; Schledermann D; Mogensen O; Jochumsen KM
Int J Gynecol Cancer; 2014 Jun; 24(5):874-9. PubMed ID: 24844221
[TBL] [Abstract][Full Text] [Related]
30. [Prognosis and fertility after conservative treatment for ovarian tumors of limited malignity: review of 68 cases].
Camatte S; Rouzier R; Boccara-Dekeyser J; Pautier P; Pomel C; Lhomme C; Duvillard P; Castaigne D; Morice P
Gynecol Obstet Fertil; 2002; 30(7-8):583-91. PubMed ID: 12199041
[TBL] [Abstract][Full Text] [Related]
31. Management of borderline ovarian tumours.
Gershenson DM
Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():49-59. PubMed ID: 27780698
[TBL] [Abstract][Full Text] [Related]
32. Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.
Lavoue V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lecuru F; Lefrere-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Senechal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():214-223. PubMed ID: 30905627
[TBL] [Abstract][Full Text] [Related]
33. Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.
Matsuo K; Machida H; Mandelbaum RS; Grubbs BH; Roman LD; Sood AK; Gershenson DM
Gynecol Oncol; 2019 May; 153(2):230-237. PubMed ID: 30797590
[TBL] [Abstract][Full Text] [Related]
34. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
[TBL] [Abstract][Full Text] [Related]
35. Borderline Ovarian Tumors: Fifteen Years' Experience at a Scottish Tertiary Cancer Center.
May J; Skorupskaite K; Congiu M; Ghaoui N; Walker GA; Fegan S; Martin CW; O'Donnell RL
Int J Gynecol Cancer; 2018 Nov; 28(9):1683-1691. PubMed ID: 30365457
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary.
Uzan C; Muller E; Kane A; Rey A; Gouy S; Bendiffallah S; Duvillard P; Fauvet R; Darai E; Morice P
Ann Oncol; 2014 Jan; 25(1):166-71. PubMed ID: 24287939
[TBL] [Abstract][Full Text] [Related]
37. Borderline Ovarian Tumor in the Pediatric and Adolescent Population: A Case Series and Literature Review.
Childress KJ; Patil NM; Muscal JA; Dietrich JE; Venkatramani R
J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):48-54. PubMed ID: 28899828
[TBL] [Abstract][Full Text] [Related]
38. Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study.
Jia SZ; Xiang Y; Yang JJ; Shi JH; Jia CW; Leng JH
Hum Reprod; 2020 Feb; 35(2):328-339. PubMed ID: 32048711
[TBL] [Abstract][Full Text] [Related]
39. Laparoscopic restaging of borderline ovarian tumors.
Daraï E; Tulpin L; Prugnolle H; Cortez A; Dubernard G
Surg Endosc; 2007 Nov; 21(11):2039-43. PubMed ID: 17514402
[TBL] [Abstract][Full Text] [Related]
40. Obstetric outcomes after conservative management of ovarian borderline tumors in women of reproductive age: A single center experience.
Sobiczewski P; Piatek S; Michalski W; Kupryjańczyk J; Maciejewski T; Ołtarzewski M; Bidzinski M
Eur J Obstet Gynecol Reprod Biol; 2022 Feb; 269():126-131. PubMed ID: 34998079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
